Tirzepatide, often referred to in the context of GLP-1 T 30MG, is a dual-action injectable medication that targets both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors.

Dual Hormone Action: GLP-1 + GIP:

GLP-1 (Glucagon-Like Peptide-1)

Released after eating to help regulate blood sugar.
Stimulates insulin: Helps your body lower blood sugar by releasing insulin from the pancreas.
Suppresses glucagon: Reduces the hormone that raises blood sugar.
Slows gastric emptying: Keeps food in your stomach longer, which helps you feel full.
Reduces appetite: Signals your brain that you're satisfied.

GIP (Glucose-Dependent Insulinotropic Polypeptide)

Also released after meals.
Enhances insulin sensitivity: Helps your body use insulin more effectively.
Supports fat metabolism: May help reduce fat storage and improve energy use.
Amplifies GLP-1 effects: Works synergistically to boost weight loss and metabolic control.

GLP-1 T 30MG - TIRZEPATIDE

$200.00

Quantity

WHAT IT IS
HOW IT WORKS
POTENTIAL BENEFITS
DISCLAIMER

Drug Class: It’s a GIP/GLP-1 receptor agonist, meaning it mimics natural gut hormones to regulate blood sugar and appetite.
Brand Names: Commonly sold as Mounjaro (for type 2 diabetes) and Zepbound (for weight loss).
Dosage Forms: Available in single-dose pens ranging from 2.5 mg to 15 mg per injection, typically administered once weekly.

Why It’s So Effective

Compared to older GLP-1 drugs like semaglutide (Ozempic, Wegovy), tirzepatide’s dual mechanism offers:

Greater weight loss: Up to 20% of body weight in clinical trials.
Better blood sugar control: Especially for people with type 2 diabetes.
Improved metabolic health: Including cholesterol and blood pressure benefits.